Archive for August, 2012

Recent Rosacea Blog Posts

Epigallocatechin Gallate (EGCg) from Green Tea Shrinks Skin Cancers

An article today in the Daily Mail highlights some research into the actions of an extract from Green Tea on skin cancer tumours. Interestingly the same benefit would not be seen from drinking green tea because it is too weak in that form. Green tea has been shown to be useful topically for rosacea sufferers […]

Continue Reading

Rossoseq for the Redness of Rosacea

A new product known as Rossoseq is to be trialled as a treatment for the redness of rosacea. The trial is sponsored by a company calling itself PBB Entrepreneur Ltd. and seems to be based in Germany. 60 people are to be enrolled in the trial, which is due to be completed by October 2012. […]

Continue Reading

Comparing Sansrosa to Finacea for Redness

Galderma are surely confirming that the development of Sansrosa 0.5% Gel (CD07805/47) is nearing completion, with the posting of a proposed comparison trial with Finacea. The trial NCT01659853 will compare how effective Sansrosa is compared to Finacea. The primary outcome will be to assess, after 15 days, an improvement in facial redness. The secondary outcome […]

Continue Reading

The London Evening Standard has a Health & Beauty article today highlightinghow to relieve a red face. Dispelling the myth of a peaches and cream complexion, but staying with a fruit similie by calling it `Strawberries’ & Cream, Leah Hardy highlights the following possible ways to relieve a red face; La Roche Posay Anthelios Extreme […]

Continue Reading

T4O Pads (Terpinen-4-ol) for Ocular Demodex

An interesting new product that contains the main active ingredient from Tea Tree Oil has emerged in a new clinical trial listing. The trial titled Demodex Blepharitis Treatment Study, is sponsored by a company called Tissue Tech Inc. of Florida (who don’t seem to have a web site). Trial NCT01647217 seeks to prove that terpinen-4-ol […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.